Growing evidence suggests that ROS play a pathophysiological role in the development of cardiac hypertrophy (see Seddon et al., 2007 for review), and indicates that sGC activation might be advantageous over sGC stimulation for mitigating maladaptive cardiac hypertrophy associated oxidative stress. This evidence concerns the gene SGCB and cardiac hypertrophy.